• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

Pharmacovigilance

  • Homepage
  • Pharmacovigilance
  • New Safety Information

Notice to marketing authorisation holders on the update of Appendix V

11.05.2017

more

Recommendations for reporting variations in medicinal product documentation based on the safety signal review from the PRAC meeting held in April 2017

03.05.2017

more

Direct healthcare professional communication on updates to strength expression, dose regimens in deep vein thrombosis / pulmonary embolism and use in patients with severe renal impairment for Clexane (enoxaparin sodium)

28.04.2017

more

Meeting highlights from the CHMP meeting in April 2017

28.04.2017

more

Meeting highlights from the CMDh meeting in April 2017

28.04.2017

more

Direct healthcare professional communication on the recall of potentially impacted lots of EpiPen 0.3 mg solution for injection and EpiPen Junior 0.15 mg solution for injection (epinephrine) due to potential defects in auto-injectors

14.04.2017

more

Direct healthcare professional communication on the important additional warnings for hemorrhage and rhabdomyolysis with Cotellic (cobimetinib), including new dose modification recommendations

14.04.2017

more

Meeting highlights from the PRAC meeting in April 2017

10.04.2017

more

Meeting highlights from the CMDh meeting in March 2017

03.04.2017

more

Meeting highlights from the CHMP meeting in March 2017

30.03.2017

more

  • 1
  • 2
  • 3
  • »

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • What is Pharmacovigilance?
  • How to Report an Adverse Drug Reaction
  • New Safety Information
    • Archive 2022
    • Archive 2021
    • Archive 2020
    • Archive 2019
    • Archive 2018
    • Archive 2017
    • Archive 2016
    • Archive 2015
    • Archive 2014
    • Archive 2013
    • Archive 2012
    • Archive 2011
    • Archive 2010
    • Archive 2009
  • Direct Healthcare Professional Communication
  • Risk minimisation measures (RMM)
  • List of serious adverse reactions
  • Information for Marketing Authorisation Holders
  • Adverse Drug Reactions Reports
  • Pandemic Influenza A/H1N1
  • Information for Marketing Authorisation Holders - Electronic Transmission of ICSRs
  • Seal for Marking of Important Safety Information
  • Pharmacovigilance and Risk Assessment Committee (PRAC) - Links
  • Medicinal Products under Additional Monitoring
  • Signal management
  • Submission of Application Documentation for Assessment of Non-Interventional Trials
  • SCOPE Project
  • Access to Databases of Suspected ADRs
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2023. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.